Alacepril (INN) is an ACE inhibitor medication indicated as a treatment for hypertension.

[2] In vivo, when alacepril undergoes deacetylation, it loses a molecule similar to the amino acid phenylalanine which transforms it into captopril.

Secondly, captopril prevents the breakdown of bradykinin, a vasodilator peptide that naturally relaxes blood vessels.

Deprotection with trifluoroacetic acid completed the synthesis of alacepril (4).

This drug article relating to the cardiovascular system is a stub.